XML 41 R27.htm IDEA: XBRL DOCUMENT v3.4.0.3
Stock-Based Compensation (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Stock based compensation by job function [Line Items]    
Common Shares Available for Grant 24,100,000  
Compensation expense related to the company's stock-based compensation plans $ 32.4 $ 33.1
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]    
Stock-based compensation expense related to stock options, SAR and ESPP grants 13.2 11.6
Lease And Well [Member]    
Stock based compensation by job function [Line Items]    
Compensation expense related to the company's stock-based compensation plans 10.4 12.1
Gathering And Processing Costs [Member]    
Stock based compensation by job function [Line Items]    
Compensation expense related to the company's stock-based compensation plans 0.3 0.3
Exploration Costs [Member]    
Stock based compensation by job function [Line Items]    
Compensation expense related to the company's stock-based compensation plans 6.5 7.4
General And Administrative [Member]    
Stock based compensation by job function [Line Items]    
Compensation expense related to the company's stock-based compensation plans $ 15.2 $ 13.3
Stock Options and SARs [Member]    
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract]    
Weighted Average Fair Value of Grants (price per share) $ 20.87 $ 30.35
Expected Volatility (in hundredths) 36.45% 40.01%
Risk-Free Interest Rate (in hundredths) 1.03% 0.82%
Dividend Yield (in hundredths) 0.86% 0.73%
Expected Life (in years) 5 years 3 months 18 days 5 years 3 months 18 days
Stock Options and SARs Rollforward [Abstract]    
Outstanding at January 1 (in shares) 10,744,000 10,493,000
Granted (in shares) 5,000 30,000
Exercised (1) (in shares) [1] 258,000 (459,000)
Forfeited (in shares) (60,000) (96,000)
Outstanding at March 31 (2) (in shares) [2] 10,431,000 9,968,000
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract]    
Outstanding at January 1 (price per share) $ 67.98 $ 64.96
Granted (price per share) 69.03 91.85
Exercised (1) (price per share) [1] 43.44 47.25
Forfeited (price per share) 85.65 77.96
Outstanding at March 31 (2) (price per share) [2] $ 68.48 $ 65.73
Stock Options and SARs Vested or Expected to Vest (in shares) [3] 10,060,000 9,586,000
Weighted average grant price for stock options/SARs vested or expected to vest (price per share) [3] $ 68.04 $ 65.09
Stock Options and SARs Exercisable at March 31 (in shares) [4] 5,770,000 4,882,000
Stock Options and SARs Exercisable at March 31 (price per share) [4] $ 58.68 $ 49.85
Unrecognized compensation expense $ 88.8  
Weighted average period over which unrecognized compensation expense will be recognized (in years) 2 years 6 months  
ESPP [Member]    
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract]    
Weighted Average Fair Value of Grants (price per share) $ 17.56 $ 23.39
Expected Volatility (in hundredths) 36.79% 37.47%
Risk-Free Interest Rate (in hundredths) 0.49% 0.11%
Dividend Yield (in hundredths) 0.82% 0.72%
Expected Life (in years) 6 months 6 months
Restricted Stock and Restricted Stock Units [Member]    
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract]    
Unrecognized compensation expense $ 156.0  
Weighted average period over which unrecognized compensation expense will be recognized (in years) 2 years 6 months  
Share-Based Compensation Arrangement By Restricted Stock And Restricted Stock Units Compensation Cost $ 18.7 $ 21.2
Restricted Stock/Restricted Stock Units and Performance Units/Performance Stock [Roll Forward]    
Outstanding at January 1 (in shares) 4,908,000 5,394,000
Granted (in shares) 284,000 438,000
Released (in shares) [5] (353,000) (365,000)
Forfeited (in shares) (39,000) (44,000)
Outstanding at March 31 (2) (in shares) [6] 4,800,000 5,423,000
Weighted Average Grant Price Restricted Stock and Restricted Stock Units/Performance Units and Performance Stock [Roll Forward]    
Outstanding at January 1 (price per share) $ 70.35 $ 64.39
Granted (price per share) 75.26 87.93
Released (price per share) [5] 53.88 51.22
Forfeited (price per share) 75.35 76.19
Outstanding at March 31 (2) (price per share) [6] $ 71.81 $ 67.08
Performance Units and Performance Stock [Member]    
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract]    
Unrecognized compensation expense $ 5.5  
Weighted average period over which unrecognized compensation expense will be recognized (in years) 3 years  
Restricted Stock/Restricted Stock Units and Performance Units/Performance Stock [Roll Forward]    
Outstanding at January 1 (in shares) 405,000  
Granted (in shares) 142,556  
Released (in shares) (134,016)  
Outstanding at March 31 (2) (in shares) 413,540  
Weighted Average Grant Price Restricted Stock and Restricted Stock Units/Performance Units and Performance Stock [Roll Forward]    
Intrinsic value of restricted stock and restricted stock units released during the year $ 9.7  
Performance Units and Performance Stock [Abstract]    
Minimum Performance Units and Stock Allowed to be Outstanding 151,096  
Maximum Performance Units and Stock Allowed to be Outstanding 675,984  
Share-Based Compensation Arrangement By Performance Units and Performance Stock Compensation Cost $ 0.5 $ 0.3
Maximum Vest Period from the Date of Grant 5 years  
Performance Period for Performance units and shares 3 years  
Minimum Performance Multiple at the Completion of the Performance Period 0.00%  
Maximum Performance Multiple at the Completion of the Performance Period 200.00%  
[1] The total intrinsic value of stock options/SARs exercised for the three months ended March 31, 2016 and 2015 was $7.3 million and $20.1 million, respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the grant price of the stock options/SARs.
[2] The total intrinsic value of stock options/SARs outstanding at March 31, 2016 and 2015 was $122.1 million and $279.5 million, respectively. At March 31, 2016 and 2015, the weighted average remaining contractual life was 3.9 years and 4.2 years, respectively.
[3] The total intrinsic value of stock options/SARs vested or expected to vest at March 31, 2016 and 2015 was $121.1 million and $274.1 million, respectively. At March 31, 2016 and 2015, the weighted average remaining contractual life was 3.9 years and 4.1 years, respectively.
[4] The total intrinsic value of stock options/SARs exercisable at March 31, 2016 and 2015 was $108.7 million and $204.5 million, respectively. At March 31, 2016 and 2015, the weighted average remaining contractual life was 2.7 years and 2.8 years, respectively.
[5] The total intrinsic value of restricted stock and restricted stock units released for the three months ended March 31, 2016 and 2015 was $24.7 million and $32.8 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the restricted stock and restricted stock units are released.
[6] The total intrinsic value of restricted stock and restricted stock units outstanding at March 31, 2016 and 2015 was $348.4 million and $497.3 million, respectively.